An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

With diabetes rates climbing, an upcoming workshop series at the YMCA will provide valuable information and support to those combating the disease. The six-week series on diabetes self-management will ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

Therefore, these cannot serve as a valid reason for the insurance company to deny a claim. A claim was rejected by the insurance company because the deceased did not disclose that he was suffering ...

With the rate of diabetes growing worldwide, it can feel like the condition is tough to avoid. A large Japanese study reveals ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...